11 results for "Ismail Essadi"
Showing 1–11 · 1.61 seconds · RSS
-
Journal Article Full text
Giant cutaneous pseudolymphoma
A 53-year-old male without significant medical history, presented to our department with a giant tumor mass of the left interscapular region measuring 25 X 13 cm. Physical exam had found a multilobulated mass fixed to the deep plane, with cutaneous infiltration and bluish aspect of the skin…
-
Journal Article Full text
Pituitary metastasis of rhabdomyosarcoma: a case report and review of the literature
INTRODUCTION: The pituitary gland is an uncommon site for metastases, in particular from rhabdomyosarcoma. Some authors have reported a recent increase in the incidence of metastases at infrequent sites, such as brain or bone, probably due to the expanded treatment options and the resulting…
-
Journal Article
Should we optimise or revise the management of initially unresectable stage III non-small cell lung cancer: rethinking consolidation therapy
Despite the PACIFIC trial transforming unresectable stage III non-small cell lung cancer (NSCLC) management, survival gains remain modest and heterogeneous. Current consolidation strategies are fragmented, with redundant “me-too” designs, underuse of dynamic biomarkers, and little consensus on…
-
Journal Article
Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study
BackgroundImmune checkpoint inhibitors are the go-to therapeutic option for relapsed non-small cell lung cancer (NSCLC) with unidentified oncogenic drivers when first-line platin doublet chemotherapy fails. Meanwhile, few options exist for the treatment of relapsed patients with small cell lung…
-
Journal Article
Oxaliplatin and/or gemcitabine vs. FOLFIRINOX in first-line Advanced pancreatic adenocarcinoma: Real-world efficacy and safety data of moroccan patients
Background: While fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) offers a survival advantage in advanced pancreatic adenocarcinoma (PAC) compared to gemcitabine, gemcitabine-oxaliplatin, and gemcitabine-nab-paclitaxel, the outcome of these regimens in African countries is still…
-
Journal Article
A comprehensive analysis of lung cancer status changes over 10 years: results of Moroccan cohort
Abstract Background Assessing long-term trends in lung cancer (LC) patients is challenging, particularly in regions with limited data. We present findings from a real-life Moroccan cohort. Methods This is a retrospective study that included patients diagnosed with LC as a primary malignancy between…
-
Journal Article
Radiation-induced chondrosarcoma of the scapula after radiotherapy for lung cancer: a case report and review of the literature
Abstract Background Radiotherapy associated with chemotherapy is a well-established treatment modality for locally advanced non-small cell lung cancers. Radiation-induced second malignancies, particularly radiation-induced sarcomas, are rare. Some authors reported a recent increase in the incidence…
-
Journal Article
Successful management of retinal metastasis from renal cancer with everolimus in a monophthalmic patient: a case report
Abstract Background The retina is an uncommon site for metastases, in particular from solid tumors. Some authors have reported a recent increase in the incidence of metastases in infrequent sites, such as brain or bone, probably due to the expanded treatment options and the resulting improved…
-
Journal Article
Advanced Treatments in Non-Clear Renal Cell Carcinoma
PURPOSE: To focus on the use of targeted therapies against the non-clear histologic subtypes of renal cell carcinoma (RCC); papillary I and II, chromophobe, and collecting duct. The unique genetic and molecular profiles of each distinct non-clear kidney cancer subtype will be described, as these…
-
Journal Article
Solitary Fibrous Tumor: Case Report of Intrapulmonary Location
Solitary fibrous tumors are relatively rare neoplasms that commonly occur in the pleura, especially visceral pleura. However, an intrapulmonary site of this kind of tumors is even rarer. These tumors can be characterized by a heterogeneous evolution and have a benign or malignant behavior. Wide…
-
Journal Article Full text
Splenic abscess in cancer chemotherapy
BACKGROUND: Splenic abcess is an uncommon complication for cancer treatment. It occurs more frequently in immunocompromised patients. They are characterized by high mortality. The classic triad (fever, pain of the left hypochondrium, and sensitive mass left) is only present in one-third of cases…